| Title |
Clinical value of metagenomic next-generation sequencing by Illumina and Nanopore for the detection of pathogens in bronchoalveolar lavage fluid in suspected community-acquired pneumonia patients |
| Description |
At present, metagenomic next-generation sequencing (mNGS) based on Illumina platform has been widely reported for pathogen detection. There are few studies on the diagnosis of major pathogens and treatment regulation using mNGS based on Illumina versus Nanopore. We aim to evaluate the clinical value of metagenomic next-generation sequencing (mNGS) by Illumina and Nanopore for the detection of pathogens in bronchoalveolar lavage fluid (BALF) in suspected community-acquired pneumonia (CAP) patients. |
| Organism |
Bacteria |
| Data Type |
Genome Binding/Occupancy Profiling |
| Data Accessibility |
Open-access |
| BioProject |
PRJCA027972 |
| Release Date |
2024-07-12 |
| Submitter |
Chi Zhu (576100123@qq.com) |
| Organization |
Jiangsu Simcere Diagnostics Co., Ltd. |
| Submission Date |
2024-07-11 |